Alpha Cognition INC. (ACOG) — SEC Filings

Overview

Alpha Cognition INC. (ACOG) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 4 filed on Mar 26, 2026: On March 24, 2026, Opaleye Management Inc. reported a change in beneficial ownership of securities for Alpha Cognition Inc. The filing, dated March 26, 2026, details transactions related to Alpha Cognition Inc.'s securities.

Sentiment Summary

Across 41 filings, the sentiment breakdown is: 1 bearish, 39 neutral, 1 mixed. The dominant filing sentiment for Alpha Cognition INC. is neutral.

Filing Type Overview

Alpha Cognition INC. (ACOG) has filed 1 4, 5 10-Q, 2 8-K/A, 19 8-K, 1 DEFA14A, 1 DEF 14A, 1 10-K, 8 S-1/A, 2 S-1, 1 SC 13D/A with the SEC between Apr 2024 to Mar 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (41)

• Opaleye Management Inc. Reports Alpha Cognition Inc. Security Changes — 4 · Mar 26, 2026 Risk: low
  On March 24, 2026, Opaleye Management Inc. reported a change in beneficial ownership of securities for Alpha Cognition Inc. The filing, dated March 26, 2026, de
• ACOG's ZUNVEYL Launch Drives Revenue, But Losses Widen Amid Soaring SG&A — 10-Q · Nov 13, 2025 Risk: high
  Alpha Cognition Inc. (ACOG) reported a significant increase in revenue for the nine months ended September 30, 2025, reaching $7,427,199, compared to no revenue
• Alpha Cognition Inc. Amends 8-K Filing — 8-K/A · Oct 15, 2025 Risk: low
  Alpha Cognition Inc. filed an amendment (8-K/A) on October 15, 2025, to a previous Form 8-K dated October 10, 2025. This amendment pertains to changes in the re
• Alpha Cognition Inc. Changes Certifying Accountant — 8-K · Oct 14, 2025 Risk: low
  Alpha Cognition Inc. filed an 8-K on October 14, 2025, reporting a change in its certifying accountant. The company, formerly known as Neurodyn Cognition Inc. u
• Alpha Cognition Inc. Files 8-K with Material Agreements — 8-K · Oct 2, 2025 Risk: medium
  Alpha Cognition Inc. filed an 8-K on October 2, 2025, reporting on events as of September 30, 2025. The filing indicates the entry into a material definitive ag
• Alpha Cognition Inc. Enters Material Definitive Agreement — 8-K · Aug 22, 2025 Risk: medium
  Alpha Cognition Inc. announced on August 22, 2025, that it has entered into a material definitive agreement. The company, formerly known as Neurodyn Cognition I
• Alpha Cognition's Revenue Soars Post-FDA Nod, But Losses Widen — 10-Q · Aug 14, 2025 Risk: high
  Alpha Cognition Inc. (ACOG) reported a significant increase in total revenue to $4,586,341 for the six months ended June 30, 2025, compared to no revenue in the
• Alpha Cognition Inc. Files 8-K: Officer Changes & Shareholder Votes — 8-K · Jun 23, 2025 Risk: medium
  Alpha Cognition Inc. filed an 8-K on June 23, 2025, reporting events as of June 19, 2025. The filing covers the departure of directors or certain officers, the
• Alpha Cognition Inc. Files 10-Q for Q1 2025 — 10-Q · May 15, 2025 Risk: low
  Alpha Cognition Inc. filed its 10-Q for the quarterly period ended March 31, 2025. The company, formerly known as Neurodyn Cognition Inc., is incorporated in Br
• Alpha Cognition Files Definitive Additional Materials — DEFA14A · May 6, 2025 Risk: low
  Alpha Cognition Inc. filed a Definitive Additional Materials (DEFA14A) on May 6, 2025. This filing relates to their proxy statement and is not a preliminary fil
• Alpha Cognition Inc. Files Definitive Proxy Statement — DEF 14A · Apr 30, 2025 Risk: medium
  Alpha Cognition Inc. filed its definitive proxy statement (DEF 14A) on April 30, 2025, for its annual meeting on June 19, 2025. The company, formerly known as N
• Alpha Cognition Inc. Reports Board and Executive Changes — 8-K · Apr 10, 2025 Risk: medium
  Alpha Cognition Inc. announced on April 7, 2025, a change in its board of directors and executive compensation arrangements. The filing details the departure of
• Alpha Cognition Inc. Files 2024 Annual Report — 10-K · Mar 31, 2025 Risk: low
  Alpha Cognition Inc. filed its 10-K for the fiscal year ended December 31, 2024. The company, formerly known as Neurodyn Cognition Inc. until October 16, 2015,
• Alpha Cognition Inc. Reports Director/Officer Changes & Financials — 8-K · Feb 27, 2025 Risk: medium
  Alpha Cognition Inc. filed an 8-K on February 27, 2025, reporting on events that occurred on February 18, 2025. The filing covers the departure of directors or
• Alpha Cognition Inc. Files S-1/A Amendment — S-1/A · Jan 10, 2025 Risk: medium
  Alpha Cognition Inc. filed an S-1/A amendment on January 10, 2025, for its registration statement. The company, formerly known as Neurodyn Cognition Inc., is in
• Alpha Cognition Inc. Files S-1 Registration Statement — S-1 · Dec 31, 2024 Risk: medium
  Alpha Cognition Inc. filed an S-1 registration statement on December 31, 2024, to register securities. The company, formerly known as Neurodyn Cognition Inc. un
• Alpha Cognition Inc. Reports Unregistered Equity Sales — 8-K · Dec 20, 2024 Risk: medium
  Alpha Cognition Inc. filed an 8-K on December 20, 2024, reporting unregistered sales of equity securities as of December 16, 2024. The filing also includes fina
• Alpha Cognition Inc. Files 8-K with Material Agreements — 8-K · Nov 18, 2024 Risk: medium
  Alpha Cognition Inc. entered into a material definitive agreement on November 12, 2024. The company also reported on unregistered sales of equity securities and
• Havens Amends Alpha Cognition Stake Filing — SC 13D/A · Nov 15, 2024 Risk: medium
  John Prentiss Havens filed an amendment to Schedule 13D on November 15, 2024, regarding Alpha Cognition Inc. The filing indicates a change in beneficial ownersh
• Alpha Cognition Inc. Files Q3 2024 10-Q Report — 10-Q · Nov 14, 2024 Risk: low
  Alpha Cognition Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2024. The company, previously known as Neurodyn Cognition Inc.,
• Alpha Cognition Inc. Amends S-1 Registration — S-1/A · Nov 6, 2024 Risk: medium
  Alpha Cognition Inc. filed an S-1/A amendment on November 6, 2024, for its registration statement (No. 333-280196). The company, formerly known as Neurodyn Cogn
• Alpha Cognition Inc. Files 8-K on Security Holder Rights — 8-K · Nov 5, 2024 Risk: medium
  Alpha Cognition Inc. filed an 8-K on November 5, 2024, reporting a material modification to the rights of security holders and financial statements as of Octobe
• Alpha Cognition Inc. Files S-1/A Amendment — S-1/A · Oct 25, 2024 Risk: medium
  Alpha Cognition Inc. filed an S-1/A amendment on October 25, 2024, for its registration statement (No. 333-280196). The company, formerly known as Neurodyn Cogn
• Alpha Cognition Inc. Files 8-K on Director Changes and Compensation — 8-K · Oct 24, 2024 Risk: medium
  Alpha Cognition Inc. filed an 8-K on October 24, 2024, reporting on the departure of directors or certain officers, the election of directors, and compensatory
• Alpha Cognition Inc. Files S-1/A Amendment — S-1/A · Oct 16, 2024 Risk: medium
  Alpha Cognition Inc. filed an S-1/A amendment on October 16, 2024, for its registration statement (No. 333-280196). The company, formerly known as Neurodyn Cogn
• Alpha Cognition Inc. Reports Board and Executive Changes — 8-K · Oct 9, 2024 Risk: medium
  Alpha Cognition Inc. announced on October 8, 2024, a change in its board of directors and executive compensation arrangements. The filing details the departure
• Alpha Cognition Inc. Files 8-K with Corporate Updates — 8-K · Oct 3, 2024 Risk: low
  Alpha Cognition Inc. filed an 8-K on October 3, 2024, reporting events as of September 27, 2024. The filing indicates amendments to articles of incorporation or
• Alpha Cognition Files 8-K/A Amendment — 8-K/A · Sep 26, 2024 Risk: low
  Alpha Cognition Inc. filed an amendment (8-K/A) on September 26, 2024, to its current report originally filed on September 24, 2024. This amendment pertains to
• Alpha Cognition Inc. Files 8-K: Material Agreement & Equity Sales — 8-K · Sep 25, 2024 Risk: medium
  Alpha Cognition Inc. entered into a material definitive agreement on September 24, 2024, which also created a direct financial obligation. The company also repo
• Alpha Cognition Inc. Files 8-K — 8-K · Aug 28, 2024 Risk: low
  Alpha Cognition Inc. filed an 8-K on August 28, 2024, to report other events and financial statements. The filing does not contain specific details about the na
• Alpha Cognition Board Changes Announced — 8-K · Aug 27, 2024 Risk: medium
  Alpha Cognition Inc. announced on August 27, 2024, a change in its board of directors. Specifically, the company reported the departure of Director Dr. Daniel G
• Alpha Cognition Inc. Files 8-K on Financials — 8-K · Aug 13, 2024 Risk: low
  Alpha Cognition Inc. filed an 8-K on August 13, 2024, reporting on its financial condition and results of operations as of August 12, 2024. The company, formerl
• Alpha Cognition Inc. Files Q2 2024 10-Q Report — 10-Q · Aug 12, 2024 Risk: low
  Alpha Cognition Inc. filed its quarterly report on Form 10-Q for the period ended June 30, 2024. The company, formerly known as Neurodyn Cognition Inc., is inco
• Alpha Cognition Inc. Reports Material Rights Modification — 8-K · Aug 9, 2024 Risk: medium
  Alpha Cognition Inc. filed an 8-K on August 9, 2024, reporting a material modification to the rights of its security holders as of August 6, 2024. The filing in
• Alpha Cognition Inc. Files S-1/A Amendment — S-1/A · Jul 30, 2024 Risk: medium
  Alpha Cognition Inc. filed an S-1/A amendment on July 29, 2024, for its registration statement (No. 333-280196). The company, formerly known as Neurodyn Cogniti
• Alpha Cognition Files 8-K — 8-K · Jul 29, 2024 Risk: medium
  Alpha Cognition Inc. filed an 8-K on July 29, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as N
• Alpha Cognition Inc. Files 8-K for Material Definitive Agreement — 8-K · Jun 14, 2024 Risk: medium
  Alpha Cognition Inc. announced on June 10, 2024, that it entered into a material definitive agreement. The company, formerly known as Neurodyn Cognition Inc., i
• Alpha Cognition Inc. Files S-1/A Amendment — S-1/A · Jun 4, 2024 Risk: medium
  Alpha Cognition Inc. filed an S-1/A amendment on June 3, 2024, for its registration statement (No. 333-278997). The company, formerly known as Neurodyn Cognitio
• Alpha Cognition Inc. Files S-1/A Amendment — S-1/A · May 22, 2024 Risk: medium
  Alpha Cognition Inc. filed an S-1/A amendment on May 22, 2024, for its registration statement (No. 333-278997). The company, formerly known as Neurodyn Cognitio
• Alpha Cognition Inc. Files Amendment No. 1 to S-1 Registration Statement — S-1/A · May 10, 2024 Risk: low
  Alpha Cognition Inc. (ACOG) filed a Amended IPO Registration (S-1/A) with the SEC on May 10, 2024. Alpha Cognition Inc. filed an S-1/A (Amendment No. 1) with th
• Alpha Cognition Inc. Files S-1 Registration Statement — S-1 · Apr 30, 2024 Risk: low
  Alpha Cognition Inc. (ACOG) filed a IPO Registration (S-1) with the SEC on April 30, 2024. Alpha Cognition Inc. has filed an S-1 registration statement with the

Risk Profile

Risk Assessment: Of ACOG's 41 recent filings, 2 were flagged as high-risk, 25 as medium-risk, and 14 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Financial Highlights

Key financial metrics from Alpha Cognition INC.'s most recent 10-Q filing (Nov 13, 2025):

• Revenue: $7,427,199
• Net Income: $(13,813,569)
• EPS: N/A
• Debt-to-Equity: 0.36
• Cash Position: $35,398,899
• Operating Margin: -197.7%
• Total Assets: $46,301,213
• Total Debt: $12,387,403

Key Executives

• Michael McFadden
• John Prentiss Havens
• Jason K. Brenkert
• Dr. Daniel G. Amen
• Dr. David L. Kern
• Jason K. Brenkert, Esq.

Industry Context

The pharmaceutical and biotechnology industry is characterized by high R&D costs, lengthy development cycles, and stringent regulatory oversight. Companies often rely on significant external financing to fund operations until a product gains market approval and generates substantial revenue. The market for neurological treatments, where ZUNVEYL operates, is competitive and requires effective commercialization strategies to capture market share.

Top Tags

sec-filing (9) · amendment (8) · registration-statement (6) · material-agreement (5) · corporate-governance (5) · financials (4) · corporate-actions (3) · 10-Q (3) · quarterly-report (3) · 8-K (3)

Key Numbers

• Period of Report: 2026-03-24 — Date of the reported ownership change
• Filing Date: 2026-03-26 — Date the Form 4 was filed with the SEC
• Total Revenue: $7,427,199 — For the nine months ended September 30, 2025, up from $0 in 2024, driven by ZUNVEYL commercialization.
• Net Loss: $(13,813,569) — For the nine months ended September 30, 2025, a significant increase from $(8,978,129) in 2024.
• Selling, General and Administrative Expenses: $19,185,161 — For the nine months ended September 30, 2025, a substantial increase from $6,380,453 in 2024, reflecting commercialization efforts.
• Cash and Cash Equivalents: $35,398,899 — As of September 30, 2025, down from $48,546,210 at December 31, 2024.
• Net Cash Used in Operating Activities: $(13,473,949) — For the nine months ended September 30, 2025, indicating significant cash burn.
• Common Shares Outstanding: 21,742,104 — As of November 13, 2025, indicating potential dilution from financing activities.
• Product Revenue, net: $4,257,562 — For the nine months ended September 30, 2025, representing initial ZUNVEYL sales.
• Licensing Revenue: $3,169,637 — For the nine months ended September 30, 2025, contributing to total revenue.
• Selling, General & Administrative Expenses: $11.90M — Increased 142.9% from $4.91M, a primary driver of increased net loss.
• Loss on Warrant Liabilities: $4.02M — Significant non-operating expense contributing to the net loss.
• Warrant Liabilities: $9.84M — Increased from $5.82M, representing potential future dilution or financial obligation.
• Net Loss Per Share: $0.78 — Increased from $1.21 in prior year (due to higher share count), but still a significant loss per share.
• Filing Type: DEF 14A — Definitive Proxy Statement

Related Companies

ALFA · ALPH

Frequently Asked Questions